Calloway Nathaniel 4
4 · LIFECORE BIOMEDICAL, INC. \DE\ · Filed Jan 10, 2024
Insider Transaction Report
Form 4
Calloway Nathaniel
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-01-09−5,906→ 0 totalFrom: 2024-01-09→ Common Stock (5,906 underlying) - Exercise/Conversion
Common Stock
2024-01-09+5,906→ 24,088 total
Footnotes (2)
- [F1]The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
- [F2]The restricted stock units vested on January 9, 2024.